Zusammenfassung
In diesem Artikel werden mögliche Assoziationen von rheumatischen Krankheiten mit häufigen und weniger häufigen hämatologischen Manifestationen beschrieben. Dabei wird insbesondere auf verschiedene Formen der Anämie, Leukopenie und Thrombopenie bei rheumatischen Erkrankungen eingegangen. Die Manifestation von malignen Tumoren bei RA und Kollagenosen sowie mögliche Ursachen werden ebenfalls diskutiert. Darüber hinaus sind auch rheumatische Manifestationen bei hämatologischen Krankheiten Thema dieser Übersicht. Ziel des Artikels ist es, einen Überblick über die vielfältigen Assoziationen von rheumatischen und hämato-/onkologischen Erkrankungen zu geben, die in der klinischen Praxis von Bedeutung sein könnten.
Summary
The association of rheumatic diseases with common and some of the less common hematological features such as different forms of anemia, leukopenia and thrombopenia are described in this article. In addition, the occurrence of malignancy in rheumatoid arthritis, systemic lupus erythematosus, myositis and scleroderma and possible causes are discussed. On the other hand, this review also focuses on various rheumatological manifestations of hematological diseases such as leukemia and lymphoma. The aim of the article is to give an overview of the various associations between rheumatological and hemato-/oncological diseases that have to be considered in clinical practice.
References
Abdou NI (1983) Heterogeneity of bone marrow-directed immune mechanisms in the pathogenesis of neutropenia of Felty’s syndrome. Arthritis Rheum 26:947–953
Baecklund E, Sundstrom C, Ekbom A, Catrina AI, Biberfeld P, Feltelius N, Klareskog L (2003) Lymphoma subtypes in patients with rheumatoid arthritis: increased proportion of diffuse large B cell lymphoma. Arthritis Rheum 48:1543–1550
Baer AN, Dessypris EN, Krantz SB (1990) The pathogenesis of anemia in rheumatoid arthritis: a clinical and laboratory analysis. Semin Arthritis Rheum 19(4):209–223
Björndal L, Löfström B, Yin L, Lundberg IE, Ekbom A (2002) Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus. Scand J Rheumatol 31:66–71
Bowman SJ, Sivakumaran M, Snowden N, Bhavnani M, Hall MA, Panayi GS, Lanchbury JS (1994) The large granular lymphocyte syndrome with rheumatoid arthritis. Immunogenetic evidence for a broader definition of Felty’s syndrome. Arthritis Rheum 37:1326–1330
Bowman SJ (2002) Hematological manifestations of rheumatoid arthritis. Scand J Rheumatol 31:251–259
Carsons S (1997) The association of malignancy with rheumatic and connective tissue diseases. Semin Oncol 24:360–372
Coppo P, Sibilia J, Maloisel F, Schlageter MH, Voyer AL, Gouilleux-Gruart V, Goetz J, Desablens B, Tribout B, Lassoued K (2003) Primary Sjögren’s syndrome associated agranulocytosis: a benign disorder? Ann Rheum Dis 62:476–478
Daughaday WH (1968) Lupus erythematosus with severe anemia, selective erythroid hypoplasia and multiple red cell isoantibodies. Am J Med 44:590–598
Dessypris EN, Baer MR, Sergent JS, Krantz SB (1984) Rheumatoid arthritis and pure red cell aplasia. Ann Intern Med 100:202–206
Ehrenfeld M, GurH, Shoenfeld Y (1999) Rheumatologic features of hematologic disorders. Curr Opin Rheum 11:62–67
Felty AR (1924) Chronic arthritis in the adult associated with splenomegaly and leukopenia: a report of five cases of an unusual clinical syndrome. Johns Hopk Hosp Bull 35:16–20
Fitzsimons EJ, Sturrock RD (2002) The chronic anemia of rheumatoid arthritis: iron banking or blocking? Lancet 360:1713–1714
Hay CR (1998) Acquired haemophilia. Baillieres Clin Haematol 11:287–303
Keeling DM, Isenberg DA (1993) Haematological manifestations of systemic lupus erythematosus. Blood Rev 7:199–207
Lanchbury JS, Jaeger EE, Sansom DM, Hall MA, Wordsworth P, Stedeford J, Bell JI, Panayi GS (1991) Strong primary selection for the Dw4 subtype of DR4 accounts for the HLA-DQw7 association with Felty’s syndrome. Hum Immunol 32:56–64
Loughran TP, Starkebaum G (1987) Large granular lymphocyte leukemia. Report of 38 cases and review of the literature. Medicine 66:397–405
Mellemkjaer L, Andersen V, Linet MS, Gridley G, Hoover R, Olsen JH (1997) Non-Hodgkin’s lymphoma and others cancers among a cohort of patients with systemic lupus erythematosus. Arthritis Rheum 40:761–768
Miesbach W, Scharrer I (2004) Das Antiphospholipid-Syndrom. Klinische Manifestationen, Diagnostik und Therapie. DMW 129:2547–2552
Molad Y, Okon E, Stark P, Prokocimer M (2001) Sjögren’s syndrome associated Tcell large granular lymphocyte leukemia: a possible common etiopathogenesis. J Rheumatol 28:2551–2552
Papadaki HA, Kritikos HD,Valatas V, Boumpas DT, Eliopoulos GD (2002) Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti-tumor necrosis factor-alpha therapy. Blood 100:474–482
Papadaki HA, Kritikos HD, Gemetzi C, Koutala H, Marsh JC, Boumpas DT, Eliopoulos GD (2002) Bone marrow progenitor cell reserve and function and stromal cell function are defective in rheumatoid arthritis: evidence for a tumor necrosis factor alpha-mediated effect. Blood 99:1610–1619
Peeters HR, Jongen-Lavrencic M, Bakker CH, Vreugdenhil G, Breedveld FC, Swaak AJ (1999) Recombinant human erythropoietin improves health-related quality of life in patients with rheumatoid arthritis and anemia of chronic disease: utility measures correlate strongly with disease activity measures. Rheumatol Int 18:201–206
Ramakrishna R, Chaudhuri K, Sturgess A, Manoharan A (1992) Haematological manifestations of primary Sjogren’s syndrome: a clinicopathological study. Q J Med 83:547–554
Reuss-Borst MA, Pawelec G, Saal JG, Horny HP, Muller CA, Waller HD (1993) Sweet’s syndrome associated with myelodysplasia: possible role of cytokines in the pathogenesis of the disease. Br J Haematol 84:356–358
Starkebaum G, Loughran TP, Gaur LK, Davis P, Nepom BS (1997) Immunogenetic similarities between patients with Felty’s syndrome and those with clonal expansions of large granular lymphocytes in rheumatoid arthritis. Arthritis Rheum 40:624–626
Sultan SM, Begum S, Isenberg DA (2003) Prevalence, patterns of disease and outcome in patients with systemic lupus erythematosus who develop severe haematological problems. Rheumatology 42:230–234
Ustun C, Kallab A, Loebl D, Jillela A, Majewski B, Mazzella F, Burgess R (2002) Rheumatoid arthritis and immune thrombocytopenia: a report of two cases. Clin Rheumatol 21:543–544
Van der Rijn M, Cleary ML, Variakojis D, Warnke RA, Chang PP, Kamel OW (1996) Epstein-Barr virus clonality in lymphomas occurring in patients with rheumatoid arthritis. Arthritis Rheum 39:638–642
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Reuss-Borst, M.A. Rheuma und hämato-onkologische Erkrankungen. Z. Rheumatol. 64, 3–11 (2005). https://doi.org/10.1007/s00393-005-0698-4
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s00393-005-0698-4